Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact.
VICE PRESIDENT OF MEDIA AND DIGITAL SERVICES | MEDTHINK COMMUNICATIONS
Research shows that budget cuts on advertising and marketing during times of recession have a long term negative impact. There's an immediate short term savings, but the long term ROI suffers because the lack of visibility may further depress sales and reduce market share. Consistency of messaging is lost during times of relative silence, and companies must spend extra to regain their presence in the market once the economy brightens.
Jon Hudson
In fact, recessions are a time to find great deals. Publishers are more aggressive with rates and offer better positions and integrated campaigns for less dollars. Competitors are likely pulling back on their advertising. There is less clutter and noise in the marketplace and more opportunity for your company to stand out and carve a niche for itself.
If the decision makers can't be convinced that recessions present an opportunity, then it's time to integrate new technology that creates efficiencies, and saves time and money.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.